{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:33:14Z","timestamp":1790983994364,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T00:00:00Z","timestamp":1169683200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s11095-006-9170-7","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T00:23:17Z","timestamp":1169684597000},"page":"546-554","source":"Crossref","is-referenced-by-count":33,"title":["Intestinal Absorption of Miltefosine: Contribution of Passive Paracellular Transport"],"prefix":"10.1007","volume":"24","author":[{"given":"C\u00e9cile","family":"M\u00e9nez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Buyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Dugave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Farinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,1,25]]},"reference":[{"key":"9170_CR1","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0140-6736(98)04367-0","volume":"352","author":"S. Sundar","year":"1998","unstructured":"S. Sundar, F. Rosenkaimer, M. K. Makharia, A. K. Goyal, A. K. Mandal, A. Voss, P. Hilgard, and H. W. Murray. Trial of oral miltefosine for visceral leishmaniasis. Lancet. 352:1821\u20131823 (1998).","journal-title":"Lancet"},{"key":"9170_CR2","first-page":"394","volume":"83","author":"S. Sundar","year":"2005","unstructured":"S. Sundar, and H. W. Murray. Availability of miltefosine for the treatment of kala-azar in India. Bull. World Health Organ. 83:394\u2013395 (2005).","journal-title":"Bull. World Health Organ."},{"key":"9170_CR3","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","volume":"347","author":"S. Sundar","year":"2002","unstructured":"S. Sundar, T. K. Jha, C. P. Thakur, J. Engel, H. Sindermann, C. Fischer, K. Junge, A. Bryceson, and J. Berman. Oral miltefosine for Indian visceral leishmaniasis. N. Engl. J. Med. 347:1739\u20131746 (2002).","journal-title":"N. Engl. J. Med."},{"key":"9170_CR4","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/BF02535556","volume":"22","author":"A. Breiser","year":"1987","unstructured":"A. Breiser, D. J. Kim, E. Fleer, W. Damenz, A. Drube, M. Berger, G. Nagel, H. Eibl, and C. Unger. Distribution and metabolism of hexadecylphosphocholine in mice. Lipids. 22:925\u2013926 (1987).","journal-title":"Lipids"},{"key":"9170_CR5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF00695989","volume":"31","author":"N. Marschner","year":"1992","unstructured":"N. Marschner, J. K\u00f6tting, H. Eibl, and C. Unger. Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment. Cancer Chemother. Pharmacol. 31:18\u201322 (1992).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"9170_CR6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000420838","volume":"34","author":"J. Kotting","year":"1992","unstructured":"J. Kotting, N. W. Marschner, W. Neumuller, C. Unger, and H. Eibl. Hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine: a comparison of hemolytic activity, serum binding and tissue distribution. Prog. Exp. Tumor Res. 34:131\u2013142 (1992).","journal-title":"Prog. Exp. Tumor Res."},{"key":"9170_CR7","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1039\/B314439A","volume":"6","author":"I. Rey Gomez-Serranillos","year":"2004","unstructured":"I. Rey Gomez-Serranillos, J. Minones Jr, P. Dynarowicz-Latka, E. Iribarnegaray, and M. Casas. Study of the p-A isotherms of miltefosine monolayers spread at the air\/water interface. Phys. Chem. Chem. Phys. 6:1580\u20131586 (2004).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"9170_CR8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/1520-6017(200103)90:3<298::AID-JPS5>3.0.CO;2-1","volume":"90","author":"C. Matos","year":"2001","unstructured":"C. Matos, H. Chaimovich, J. L. Lima, I. M. Cuccovia, and S. Reis. Effect of liposomes on the rate of alkaline hydrolysis of indomethacin and acemetacin. J. Pharm. Sci. 90:298\u2013309 (2001).","journal-title":"J. Pharm. Sci."},{"key":"9170_CR9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1021\/bi00571a005","volume":"18","author":"P. S. Araujo De","year":"1979","unstructured":"P. S. De Araujo, M. Y. Rosseneu, J. M. Kremer, E. J. van Zoelen, and G. H. de Haas. Structure and thermodynamic properties of the complexes between phospholipase A2 and lipid micelles. Biochemistry. 18:580\u2013586 (1979).","journal-title":"Biochemistry"},{"key":"9170_CR10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000420826","volume":"34","author":"J. Kotting","year":"1992","unstructured":"J. Kotting, N. W. Marschner, C. Unger, and H. Eibl. Determination of alkylphosphocholines and of alkyl-glycero-phosphocholines in biological fluids and tissues. Prog. Exp. Tumor Res. 34:6\u201311 (1992).","journal-title":"Prog. Exp. Tumor Res."},{"key":"9170_CR11","first-page":"5803","volume":"46","author":"D. R. Hoffman","year":"1986","unstructured":"D. R. Hoffman, L. H. Hoffman, and F. Snyder. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells. Cancer Res. 46:5803\u20135809 (1986).","journal-title":"Cancer Res."},{"key":"9170_CR12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/BF02535537","volume":"22","author":"W. J. Blitterswijk Van","year":"1987","unstructured":"W. J. Van Blitterswijk, H. Hilkmann, and G. A. Storme. Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion. Lipids. 22:820\u2013823 (1987).","journal-title":"Lipids"},{"key":"9170_CR13","doi-asserted-by":"crossref","first-page":"49965","DOI":"10.1074\/jbc.M308352200","volume":"278","author":"F. J. Perez-Victoria","year":"2003","unstructured":"F. J. Perez-Victoria, F. Gamarro, M. Ouellette, and S. Castanys. Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance. J. Biol. Chem. 278:49965\u201349971 (2003).","journal-title":"J. Biol. Chem."},{"key":"9170_CR14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jps.2600790604","volume":"79","author":"P. Artursson","year":"1990","unstructured":"P. Artursson. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 79:476\u2013482 (1990).","journal-title":"J. Pharm. Sci."},{"key":"9170_CR15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/0016-5085(89)90897-4","volume":"96","author":"I. J. Hidalgo","year":"1989","unstructured":"I. J. Hidalgo, T. J. Raub, and R. T. Borchardt. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology. 96:736\u2013749 (1989).","journal-title":"Gastroenterology"},{"key":"9170_CR16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/jlcr.2580311216","volume":"31","author":"C. C. Geilen","year":"1992","unstructured":"C. C. Geilen, A. Samson, T. Wieder, H. Wild, and W. Reutter. Synthesis of hexadecylphospho[methyl-14C]-choline. J. Labelled Compd. Radiopharm. 31:1071\u20131076 (1992).","journal-title":"J. Labelled Compd. Radiopharm."},{"key":"9170_CR17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0009-3084(88)90033-3","volume":"47","author":"H. Eibl","year":"1988","unstructured":"H. Eibl, and P. Woolley. A general synthetic method for enantiomerically pure ester and ether lysophospholipids. Chem. Phys. Lipids. 47:63\u201368 (1988).","journal-title":"Chem. Phys. Lipids"},{"key":"9170_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T. Mosmann","year":"1983","unstructured":"T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55\u201363 (1983).","journal-title":"J. Immunol. Methods"},{"key":"9170_CR19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-1759(88)90310-9","volume":"115","author":"T. Decker","year":"1988","unstructured":"T. Decker, and M. L. Lohmann-Matthes. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J. Immunol. Methods. 115:61\u201369 (1988).","journal-title":"J. Immunol. Methods"},{"key":"9170_CR20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bcp.2005.11.008","volume":"71","author":"C. M\u00e9nez","year":"2006","unstructured":"C. M\u00e9nez, M. Buyse, H. Chacun, R. Farinotti, and G. Barratt. Modulation of intestinal barrier properties by miltefosine. Biochem. Pharmacol. 71:486\u2013496 (2006).","journal-title":"Biochem. Pharmacol."},{"key":"9170_CR21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0021-9258(18)89703-4","volume":"260","author":"B. L. Clarke","year":"1985","unstructured":"B. L. Clarke, and P. H. Weigel. Recycling of the asialoglycoprotein receptor in isolated rat hepatocytes. ATP depletion blocks receptor recycling but not a single round of endocytosis. J. Biol. Chem. 260:128\u2013133 (1985).","journal-title":"J. Biol. Chem."},{"key":"9170_CR22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jps.2600790710","volume":"79","author":"P. Artursson","year":"1990","unstructured":"P. Artursson, and C. Magnusson. Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells. J. Pharm. Sci. 79:595\u2013600 (1990).","journal-title":"J. Pharm. Sci."},{"key":"9170_CR23","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1023\/A:1018965929419","volume":"10","author":"L. S. Gan","year":"1993","unstructured":"L. S. Gan, P. H. Hsyu, J. F. Pritchard, and D. Thakker. Mechanism of intestinal absorption of ranitidine and ondansetron: transport across Caco-2 cell monolayers. Pharm. Res. 10:1722\u20131725 (1993).","journal-title":"Pharm. Res."},{"key":"9170_CR24","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1023\/A:1012111008617","volume":"14","author":"V. Pade","year":"1997","unstructured":"V. Pade, and S. Stavchansky. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model. Pharm. Res. 14: 1210\u20131215 (1997).","journal-title":"Pharm. Res."},{"key":"9170_CR25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1023\/A:1018933324914","volume":"11","author":"A. Tsuji","year":"1994","unstructured":"A. Tsuji, H. Takanaga, I. Tamai, and T. Terasaki. Transcellular transport of benzoic acid across Caco-2 cells by a pH-dependent and carrier-mediated transport mechanism. Pharm. Res. 11: 30\u201337 (1994).","journal-title":"Pharm. Res."},{"key":"9170_CR26","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1128\/AAC.41.12.2693","volume":"41","author":"M. E. Cavet","year":"1997","unstructured":"M. E. Cavet, M. West, and N. L. Simmons. Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells. Antimicrob. Agents Chemother. 41:2693\u20132698 (1997).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9170_CR27","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1023\/A:1018903931777","volume":"10","author":"P. Artursson","year":"1993","unstructured":"P. Artursson, A. L. Ungell, and J. E. Lofroth. Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm. Res. 10:1123\u20131129 (1993).","journal-title":"Pharm. Res."},{"key":"9170_CR28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1006\/bbrc.1993.2545","volume":"197","author":"L. S. Gan","year":"1993","unstructured":"L. S. Gan, T. Niederer, C. Eads, and D. Thakker. Evidence for predominantly paracellular transport of thyrotropin-releasing hormone across Caco-2 cell monolayers. Biochem. Biophys. Res. Commun. 197:771\u2013777 (1993).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"9170_CR29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0304-4165(90)90179-Z","volume":"1035","author":"I. J. Hidalgo","year":"1990","unstructured":"I. J. Hidalgo, and R. T. Borchardt. Transport of bile acids in a human intestinal epithelial cell line, Caco-2. Biochim. Biophys. Acta. 1035:97\u2013103 (1990).","journal-title":"Biochim. Biophys. Acta"},{"key":"9170_CR30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1054\/bjoc.2001.1776","volume":"84","author":"M. Rybczynska","year":"2001","unstructured":"M. Rybczynska, R. Liu, P. Lu, F. J. Sharom, E. Steinfels, A. D. Pietro, M. Spitaler, H. Grunicke, and J. Hofmann. MDR1 causes resistance to the antitumour drug miltefosine. Br. J. Cancer. 84:1405\u20131411 (2001).","journal-title":"Br. J. Cancer"},{"key":"9170_CR31","doi-asserted-by":"crossref","first-page":"C1219","DOI":"10.1152\/ajpcell.00204.2003","volume":"285","author":"H. M. Said","year":"2003","unstructured":"H. M. Said, A. Ortiz, and T. Y. Ma. A carriermediated mechanism for pyridoxine uptake by human intestinal epithelial Caco2 cells: regulation by a PKAmediated pathway. Am. J. Physiol. Cell Physiol. 285:C1219\u20131225 (2003).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"9170_CR32","first-page":"27","volume":"23","author":"A. Leroy","year":"2003","unstructured":"A. Leroy, G. K. de Bruyne, L. C. Oomen, and M. M. Mareel. Alkylphospholipids reversibly open epithelial tight junctions. Anticancer Res. 23:27\u201332 (2003).","journal-title":"Anticancer Res."},{"key":"9170_CR33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1124\/jpet.102.043638","volume":"304","author":"P. D. Ward","year":"2003","unstructured":"P. D. Ward, H. Ouyang, and D. R. Thakker. Role of phospholipase C-beta in the modulation of epithelial tight junction permeability. J. Pharmacol. Exp. Ther. 304:689\u2013698 (2003).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"9170_CR34","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1021\/js990094e","volume":"88","author":"D. Z. Liu","year":"1999","unstructured":"D. Z. Liu, E. L. LeCluyse, and D. R. Thakker. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers. J. Pharm. Sci. 88:1161\u20131168 (1999).","journal-title":"J. Pharm. Sci."},{"key":"9170_CR35","first-page":"G498","volume":"272","author":"A. Amelsberg","year":"1997","unstructured":"A. Amelsberg, C. D. Schteingart, J. Stein, W. J. Simmonds, G. A. Sawada, N. F. Ho, and A. F. Hofmann. Intestinal absorption of sodium dodecyl sulfate in the rodent: evidence for paracellular absorption. Am. J. Physiol. 272:G498\u2013506 (1997).","journal-title":"Am. J. Physiol."},{"key":"9170_CR36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF02353863","volume":"22","author":"D. E. Leahy","year":"1994","unstructured":"D. E. Leahy, J. Lynch, R. E. Finney, and D. C. Taylor. Estimation of sieving coefficients of convective absorption of drugs in perfused rat jejunum. J. Pharmacokinet. Biopharm. 22:411\u2013429 (1994).","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"9170_CR37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0169-409X(91)90013-3","volume":"7","author":"H. N. Nellans","year":"1991","unstructured":"H. N. Nellans. Mechanisms of peptide and protein absorption : (1) Paracellular intestinal transport: modulation of absorption. Adv. Drug Deliv. Rev. 7:339\u2013364 (1991).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9170_CR38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0022-3565(24)36388-8","volume":"280","author":"J. R. Pappenheimer","year":"1997","unstructured":"J. R. Pappenheimer, M. L. Karnovsky, and J. E. Maggio. Absorption and excretion of undegradable peptides: role of lipid solubility and net charge. J. Pharmacol. Exp. Ther. 280:292\u2013300 (1997).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"9170_CR39","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/js980111k","volume":"87","author":"V. Pade","year":"1998","unstructured":"V. Pade, and S. Stavchansky. Link between drug absorption solubility and permeability measurements in Caco-2 cells. J. Pharm. Sci. 87:1604\u20131607 (1998).","journal-title":"J. Pharm. Sci."},{"key":"9170_CR40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(00)00128-9","volume":"46","author":"P. Artursson","year":"2001","unstructured":"P. Artursson, K. Palm, and K. Luthman. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 46:27\u201343 (2001).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"9170_CR41","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0014-827X(99)00069-5","volume":"54","author":"E. Biganzoli","year":"1999","unstructured":"E. Biganzoli, L. A. Cavenaghi, R. Rossi, M. C. Brunati, and M. L. Nolli. Use of a Caco-2 cell culture model for the characterization of intestinal absorption of antibiotics. Il Farmaco. 54:594\u2013599 (1999).","journal-title":"Il Farmaco"},{"key":"9170_CR42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/med.2610150202","volume":"15","author":"K. M. Hillgren","year":"1995","unstructured":"K. M. Hillgren, A. Kato, and R. T. Borchardt. In vitro systems for studying intestinal drug absorption. Med. Res. Rev. 15:83\u2013109 (1995).","journal-title":"Med. Res. Rev."},{"key":"9170_CR43","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1517\/14656566.6.8.1381","volume":"6","author":"J. Berman","year":"2005","unstructured":"J. Berman. Miltefosine to treat leishmaniasis. Expert Opin. Pharmacother. 6:1381\u20131388 (2005).","journal-title":"Expert Opin. Pharmacother."},{"key":"9170_CR44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0005-2760(78)90125-X","volume":"530","author":"B. Arnold","year":"1978","unstructured":"B. Arnold, R. Reuther, and H. U. Weltzien. Distribution and metabolism of synthetic alkyl analogs of lysophosphatidylcholine in mice. Biochim. Biophys. Acta. 530:47\u201355 (1978).","journal-title":"Biochim. Biophys. Acta"},{"key":"9170_CR45","doi-asserted-by":"crossref","first-page":"36041","DOI":"10.1074\/jbc.M305263200","volume":"278","author":"P. K. Hanson","year":"2003","unstructured":"P. K. Hanson, L. Malone, J. Birchmore, and J. Nichols. Lem3p is essential for the uptake and potency of alkylphosphocholine drugs, edelfosine and miltefosine. J. Biol. Chem. 278:36041\u201336050 (2003).","journal-title":"J. Biol. Chem."},{"key":"9170_CR46","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","volume":"47","author":"F. J. Perez-Victoria","year":"2003","unstructured":"F. J. Perez-Victoria, S. Castanys, and F. Gamarro. Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug. Antimicrob. Agents Chemother. 47:2397\u20132403 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9170_CR47","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/0006-2952(93)90224-K","volume":"45","author":"E. E. Kelley","year":"1993","unstructured":"E. E. Kelley, E. J. Modest, and C. P. Burns. Unidirectional membrane uptake of the ether lipid antineoplastic agent edelfosine by L1210 cells. Biochem. Pharmacol. 45:2435\u20132439 (1993).","journal-title":"Biochem. Pharmacol."},{"key":"9170_CR48","first-page":"807","volume":"51","author":"F. Uberall","year":"1991","unstructured":"F. Uberall, H. Oberhuber, K. Maly, J. Zaknun, L. Demuth, and H. H. Grunicke. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity. Cancer Res. 51:807\u2013812 (1991).","journal-title":"Cancer Res."},{"key":"9170_CR49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0145-2126(95)00008-C","volume":"19","author":"E. C. Heesbeen","year":"1995","unstructured":"E. C. Heesbeen, G. Rijksen, H. G. van Heugten, and L. F. Verdonck. Influence of serum levels on leukemic cell destruction by the ether lipid ET-18-OCH3. Leuk. Res. 19:417\u2013425 (1995).","journal-title":"Leuk. Res."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-006-9170-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-006-9170-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-006-9170-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T05:40:41Z","timestamp":1736746841000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-006-9170-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,25]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["9170"],"URL":"https:\/\/doi.org\/10.1007\/s11095-006-9170-7","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,25]]}}}